Filing Flows › Comparisons › DGX vs NTRA
Quest Diagnostics vs Natera: DGX and NTRA compared
Quest Diagnostics is the larger company: $3.1B of revenue in its latest quarter (Q3 2026) against $794M for Natera (Q3 2026). Natera is growing faster (+34% against +10% a year earlier). Quest Diagnostics is more profitable, with an operating margin of 15.5% against -8.6%.
Where the money goes: DGX and NTRA
Quest Diagnostics (DGX) · Q3 2026
Quest Diagnostics, Q3 2026: revenue $3.1B (+10% year over year), operating margin 15.5%, net earnings $312M, operating cash flow $611M. The chart follows the revenue to costs, profit and cash.
Natera (NTRA) · Q3 2026
Natera, Q3 2026: revenue $794M (+34% year over year), operating margin -8.6%, net loss $59.9M, operating cash flow $43.9M. The chart follows the revenue to costs, profit and cash.
| Quest Diagnostics (DGX) | Natera (NTRA) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $3.1B | $794M |
| Revenue growth, Y/Y | +10% | +34% |
| Operating margin | 15.5% | -8.6% |
| Net earnings | $312M | −$59.9M |
| Net margin | 10.1% | -7.5% |
| Operating cash flow | $611M | $43.9M |
| Free cash flow | $445M | $5.3M |
| Market value | $28.7B | $44.8B |
| P/E | 25.5× | — |
| Analysts’ mean target | $257.27 | $416.39 |
Where the revenue comes from
Quest Diagnostics
- DIS business: $3.0B (98%)
- All other operating segments: $62.0M (2%)
Natera
- Product revenues: $790M (99%)
- Licensing and other revenues: $4.0M (1%)
Questions
Which is bigger, Quest Diagnostics or Natera?
Quest Diagnostics is the larger company: $3.1B of revenue in its latest quarter (Q3 2026) against $794M for Natera (Q3 2026).
Is Quest Diagnostics or Natera growing faster?
Natera is growing faster (+34% against +10% a year earlier).
Which is more profitable, Quest Diagnostics or Natera?
Quest Diagnostics is more profitable, with an operating margin of 15.5% against -8.6%.
More: Quest Diagnostics earnings · how Quest Diagnostics makes money · Natera earnings · how Natera makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 23, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.